Global Anaplastic Thyroid Cancer Drug Market Status and Outlook 2018-2025

August 2018 | 128 pages | ID: G543E961662EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Daiichi Sankyo Company, Limited
• Genelux Corporation
• Immune Pharmaceuticals Inc.
• Millennium Pharmaceuticals Inc
• Novartis AG
• Pfizer Inc.
• Plexxikon Inc.
• Trophogen, Inc.

Market by Type

• CLM-94
• Crolibulin
• Efatutazone
• GLONC-2
• Others

Market by Application

• Hospital
• Clinic
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Anaplastic Thyroid Cancer Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 CLM-94
  3.1.2 Crolibulin
  3.1.3 Efatutazone
  3.1.4 GLONC-2
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital
  4.1.2 Clinic
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 CLM-94 Production by Region
    6.1.1.2 Crolibulin Production by Region
    6.1.1.3 Efatutazone Production by Region
    6.1.1.4 GLONC-2 Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Production by Region
    6.1.2.2 Clinic Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 CLM-94 Demand by Region
    6.2.1.2 Crolibulin Demand by Region
    6.2.1.3 Efatutazone Demand by Region
    6.2.1.4 GLONC-2 Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Demand by Region
    6.2.2.2 Clinic Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Daiichi Sankyo Company, Limited
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Genelux Corporation
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Immune Pharmaceuticals Inc.
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Millennium Pharmaceuticals Inc
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Novartis AG
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Pfizer Inc.
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Plexxikon Inc.
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Trophogen, Inc.
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Anaplastic Thyroid Cancer Drug Industry Dynamics & Regulations List
Table Global Anaplastic Thyroid Cancer Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Anaplastic Thyroid Cancer Drug Market Status by Type 2015-2018E, in USD Million
Table Global Anaplastic Thyroid Cancer Drug Market Status by Application 2015-2018E, in USD Million
Table Global Anaplastic Thyroid Cancer Drug Market Status by Application 2015-2018E, in Volume
Table Global Anaplastic Thyroid Cancer Drug Market by Region 2015-2018E, in USD Million
Table Global Anaplastic Thyroid Cancer Drug Market Share by Region in 2018, in USD Million
Table Global Anaplastic Thyroid Cancer Drug Market by Region 2015-2018E, in Volume
Table Global Anaplastic Thyroid Cancer Drug Market Share by Region in 2018, in Volume
Table CLM-94 Production Value by Region 2015-2018E, in USD Million
Table CLM-94 Production Volume by Region 2015-2018E, in Volume
Table Crolibulin Production Value by Region 2015-2018E, in USD Million
Table Crolibulin Production Volume by Region 2015-2018E, in Volume
Table Efatutazone Production Value by Region 2015-2018E, in USD Million
Table Efatutazone Production Volume by Region 2015-2018E, in Volume
Table GLONC-2 Production Value by Region 2015-2018E, in USD Million
Table GLONC-2 Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table CLM-94 Market Size by Region 2015-2018E, in USD Million
Table CLM-94 Market Size by Region 2015-2018E, in Volume
Table Crolibulin Market Size by Region 2015-2018E, in USD Million
Table Crolibulin Market Size by Region 2015-2018E, in Volume
Table Efatutazone Market Size by Region 2015-2018E, in USD Million
Table Efatutazone Market Size by Region 2015-2018E, in Volume
Table GLONC-2 Market Size by Region 2015-2018E, in USD Million
Table GLONC-2 Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalAnaplastic Thyroid Cancer Drug Forecast by Type 2019F-2025F, in USD Million
Table Anaplastic Thyroid Cancer Drug Forecast by Type 2019F-2025F, in Volume
Table Anaplastic Thyroid Cancer Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Anaplastic Thyroid Cancer Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Anaplastic Thyroid Cancer Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Anaplastic Thyroid Cancer Drug Market Forecast by Region 2019F-2025F, in Volume
Table Daiichi Sankyo Company, Limited Information
Table Anaplastic Thyroid Cancer Drug Sales, Cost, Margin of Daiichi Sankyo Company, Limited
Table Genelux Corporation Information
Table Anaplastic Thyroid Cancer Drug Sales, Cost, Margin of Genelux Corporation
Table Immune Pharmaceuticals Inc. Information
Table Anaplastic Thyroid Cancer Drug Sales, Cost, Margin of Immune Pharmaceuticals Inc.
Table Millennium Pharmaceuticals Inc Information
Table Anaplastic Thyroid Cancer Drug Sales, Cost, Margin of Millennium Pharmaceuticals Inc
Table Novartis AG Information
Table Anaplastic Thyroid Cancer Drug Sales, Cost, Margin of Novartis AG
Table Pfizer Inc. Information
Table Anaplastic Thyroid Cancer Drug Sales, Cost, Margin of Pfizer Inc.
Table Plexxikon Inc. Information
Table Anaplastic Thyroid Cancer Drug Sales, Cost, Margin of Plexxikon Inc.
Table Trophogen, Inc. Information
Table Anaplastic Thyroid Cancer Drug Sales, Cost, Margin of Trophogen, Inc.
Table Global Anaplastic Thyroid Cancer Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Anaplastic Thyroid Cancer Drug Sales Volume by Company 2015-2017, in Volume
Table Global Anaplastic Thyroid Cancer Drug Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Anaplastic Thyroid Cancer Drug Picture
Figure Anaplastic Thyroid Cancer Drug Industry Chain Diagram
Figure Global Anaplastic Thyroid Cancer Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Anaplastic Thyroid Cancer Drug Sales Volume 2015-2018E, in Volume
Figure Global Anaplastic Thyroid Cancer Drug Market Status by Type 2015-2018E, in Volume
Figure North America Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Anaplastic Thyroid Cancer Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Anaplastic Thyroid Cancer Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Anaplastic Thyroid Cancer Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Anaplastic Thyroid Cancer Drug Sales Price Forecast 2019F-2025F
Figure Global Anaplastic Thyroid Cancer Drug Gross Margin Forecast 2019F-2025F
Figure Global Anaplastic Thyroid Cancer Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Anaplastic Thyroid Cancer Drug Price by Company in 2018
Figure Global Anaplastic Thyroid Cancer Drug Gross Margin by Company in 2018